SignalXSignalX

MNKD MANNKIND CORP

8-K Current Report
Filed: February 26, 2026
Health Care
Pharmaceutical Preparations
MANNKIND CORP Overview

MANNKIND CORP (MNKD) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4/FY 2025 earnings press release issued Feb 26, 2026; full results in Exhibit 99.1
  • • Investors should review Exhibit 99.1 for revenue, earnings, and pipeline updates on Tyvaso DPI and Afrezza

Get deeper insights on MANNKIND CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.